Through these various mechanisms, EPO administration reduces the severity of murine experimental autoimmune encephalomyelitis (EAE), limits development of murine interstitial nephritis, prevents clinical expression of multiple models of murine lupus nephritis (LN), and promotes murine heart transplant survival (4, 6, 8). Here, EPO is linked to lobular neoplasia.